Long-term survivors and gilteritinib safety beyond 1 year in patients with FLT3-mutated relapsed or refractory acute myeloid leukemia: ADMIRAL trial follow-up Meeting Abstract


Authors: Perl, A. E.; Martinelli, G.; Neubauer, A.; Berman, E.; Baer, M. R.; Larson, R. A.; Fathi, A. T.; Yokoyama, H.; Hosono, N.; Hasabou, N.; Lu, Q.; Tiu, R. V.
Abstract Title: Long-term survivors and gilteritinib safety beyond 1 year in patients with FLT3-mutated relapsed or refractory acute myeloid leukemia: ADMIRAL trial follow-up
Meeting Title: 61st Annual Scientific Meeting of the British Society for Haematology
Journal Title: British Journal of Haematology
Volume: 193
Issue: Suppl. 1
Meeting Dates: 2021 Apr 25-28
Meeting Location: Virtual
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2021-04-01
Start Page: 3
End Page: 4
Language: English
ACCESSION: WOS:000645412200003
PROVIDER: wos
PUBMED: 33928641
DOI: 10.1111/bjh.17490
Notes: Meeting Abstract: BSH2021-OR-002 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ellin Berman
    176 Berman